Key Client Fiduciary Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $42.1K | Buy |
|
|||||
|
2025
Q1 | $29.6K | Sell |
|
|||||
|
2024
Q4 | $138K | Hold |
|
|||||
|
2024
Q3 | $243K | Sell |
|
|||||
|
2024
Q2 | $257K | Sell |
|
|||||
|
2024
Q1 | $424K | Sell |
|
|||||
|
2023
Q4 | $267K | Buy |
|
|||||
|
2023
Q3 | $247K | Sell |
|
|||||
|
2023
Q2 | $304K | Buy |
|
|||||
|
2023
Q1 | $350K | Buy |
|
|||||
|
2022
Q4 | $433K | Sell |
|
|||||
|
2022
Q3 | $469K | Buy |
|
|||||
|
2022
Q2 | $707K | Sell |
|
|||||
|
2022
Q1 | $866K | Buy |
|
|||||
|
2021
Q4 | $960K | Buy |
|